Articles tagged with Melanoma
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
The combination of relatlimab and nivolumab doubled progression-free survival benefit compared to nivolumab alone, with significant benefits across pre-specified subgroups. The treatment was associated with a lower risk of disease progression or death.
Patients with sufficient fiber intake had improved progression-free survival and response to immunotherapy in melanoma. A high-fiber diet was associated with slower tumor growth and increased CD4+ T cells in pre-clinical models, supporting the potential benefits of dietary interventions on cancer treatment outcomes.
A research team has identified a bacterium responsible for producing palmerolide A, a melanoma-fighting compound found in Antarctic sea squirts. The discovery could lead to the development of naturally-derived treatments for skin cancer.
CNIO researchers have identified a new biomarker for early melanoma metastasis, proposing the use of NGFR to predict disease prognosis and define risk groups. Blocking NGFR drastically reduces metastasis in mice, paving the way for a potential first treatment to tackle metastasis in its earliest stages.
The CDI laboratory has identified a complex natural pathway that melanoma hijacks to metastasize. The pathway centers around the silencing of bone morphogenetic protein 6 (BMP6), leading to abnormal cell signaling and increased cancer cell motility.
A clinical trial found that giving immunotherapy before targeted therapy improves survival in advanced melanoma patients, with a two-year overall survival rate of 72% compared to 52%. The study suggests that immunotherapy should be the initial approach for treating metastatic melanoma patients, regardless of BRAF mutation status.
A Phase II study shows that combination treatment with nivolumab and ipilimumab improves overall survival in patients with asymptomatic melanoma brain metastases, with an overall survival rate of 71.9% at three years. The treatment demonstrates durable responses, even in symptomatic patients.
Researchers at West Virginia University have received FDA approval for a new drug to treat uveal melanoma, a rare form of eye cancer. The drug, MTI-201, targets specific biomarkers in diseased cells, allowing for more precise treatment with minimal damage to healthy cells.
Researchers found that melanomas detected during routine skin checks were associated with a significantly lower all-cause risk of death, but not melanoma-specific death. The study involved 2,452 patients in Australia and suggests a potential benefit to regular skin cancer screenings.
Metastases in malignant melanoma can use an alternative process to access the circulatory system, where a blood vessel divides into two parallel vessels. This finding challenges traditional research on tumor growth and may lead to new treatment options for metastatic cancer.
Researchers analyzed fecal metagenomic DNA sequencing data to see if specific donor strains correlated with successful treatment outcomes. They found no correlation between donor strains and response to anti-PD-1 therapy in melanoma patients.
Researchers discovered that adrenal gland metastases are unresponsive to checkpoint inhibitors due to the secretion of corticosteroids. Surgical removal is the current best course of action for patients with these metastases. The study's authors hope to develop a nonsurgical treatment option in the future.
The KEYNOTE-716 trial shows that adjuvant pembrolizumab significantly prolongs recurrence-free survival and halves distant recurrences in stage II B/C melanoma patients. This suggests that patients with high-risk stage II melanoma should be offered adjuvant therapy.
Researchers developed a treatment using cowpea mosaic virus nanoparticles that target lung tumors, slowing tumor growth and preventing cancer spread. The treatment showed efficacy against aggressive cancer cell lines and may offer protection to patients at high risk of metastatic disease.
A new combination treatment has shown significant tumor shrinkage and prolonged survival in patients with metastatic uveal melanoma. The treatment, which targets HDAC and PD-1 proteins, was found to work better in tumors with active BAP1 genes, a key discovery that may lead to improved survival rates.
Patients with relapsed metastatic melanoma who received prior anti-PD-1 therapies had a lower response rate to adoptive cell transfer of tumor-infiltrating lymphocytes (ACT-TIL). ACT-TIL was less effective in these patients compared to those who had never received anti-PD-1 therapy. The study found that the objective response rate and ...
Researchers developed a nanotherapeutic platform that combines camptothecin with immune checkpoint inhibitors to increase effectiveness against aggressive tumors. The approach showed promising results in eliminating difficult-to-treat late-stage metastatic colorectal cancer and melanoma tumors.
Researchers found that UVB radiation from the sun causes chemical changes to DNA, leading to disease-causing mutations. This discovery sheds light on the origins of melanoma and highlights the importance of prevention efforts.
A study found specific gut microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. The research identified a potential new strategy to treat toxicity while maintaining response through IL-1R inhibition or manipulation of the gut microbiota.
Researchers analyzed molecular analysis data from a pediatric melanoma registry, identifying diverse subgroups and their characteristics. The study found that spitzoid melanomas often have gene fusions and benign clinical courses, while conventional melanoma patients with advanced disease had poorer outcomes.
The partnership aims to reduce the risk of relapse in Stage 2 melanoma patients using BRAF and MEK targeted therapies. EORTC and Pierre Fabre will conduct a large Phase 3 study to advance research in melanoma.
A large clinical trial has shown that pembrolizumab after surgery significantly lowers the risk of disease recurrence in patients with high-risk melanoma. This treatment also results in fewer serious side effects compared to standard therapies like ipilimumab or high-dose interferon.
Haizhen Wang, a MUSC Hollings Cancer Center researcher, has received a $225,000 Young Investigator grant from the Melanoma Research Alliance. She will investigate the function of protein CDK6 in T-cells to improve melanoma therapy outcomes.
A clinical trial found that nearly half of patients treated with nivolumab and ipilimumab were alive six-and-a-half years after treatment, outperforming those who received either drug alone. The combination therapy demonstrated a durable benefit for advanced melanoma patients.
A new study reveals that small uveal melanomas have molecular genetic alterations, making them highly metastatic tumours. Prompt treatment can significantly increase the chances of cure for these patients.
Researchers at H. Lee Moffitt Cancer Center discovered that acral nevi have a distinct mutation profile compared to acral melanoma, with activating mutations in the BRAF gene being very common in acral nevi. The study found that only 10% of patients had activating mutations in the NRAS gene.
A recent study found that banning tanning beds among U.S. minors would significantly reduce the number of melanoma cases in adolescents, with estimates suggesting up to 15,101 cases prevented over the lifetime of 17.1 million minors. The study also estimated that such a ban would save millions of dollars in healthcare costs.
Researchers at the University of Colorado Cancer Center have discovered an NLRP3 inhibitor that can reduce inflammation in melanoma cells, potentially leading to reduced tumor growth and progression. The study's findings suggest that inhibiting NLRP3 could improve patient care for those resistant to checkpoint inhibitors.
Chronic side effects among melanoma survivors after anti-PD-1 immunotherapy treatment are more common than previously recognized, affecting 43% of patients. The most frequently affected organs were joints and the endocrine system.
Pre-clinical study finds NCOA3 activation contributes to melanoma development after exposure to ultraviolet light, promoting survival advantage and accumulation of DNA damage. A single nucleotide polymorphism in NCOA3 decreases protein production, increasing sensitivity to UV-mediated cell death.
A new grant will enable researcher Neil Box to conduct further follow-up work with a longitudinal study of mole development in kids, aiming to determine the effects of early sun exposure. The study aims to develop more sophisticated measures of sun damage and explore its relationship with melanoma risk.
A neural network system analyzes photographs to rank and distinguish suspicious skin lesions, suggesting it can aid clinicians in spotting precancerous marks during clinical visits. The platform's performance was demonstrated with a sensitivity and specificity of 90.3% and 89.9%, respectively, in identifying 'ugly duckling' lesions.
A new study found that altering the gut microbiome can take a patient with advanced melanoma who has never responded to immunotherapy and convert them into responders.
A new AI algorithm has demonstrated the ability to accurately diagnose skin melanoma, rivaling that of experienced dermatologists. The study used machine learning to analyze 937 images and 200 cases, with results showing no significant difference between human dermatologists and the algorithm in making classifications.
A study by Texas A&M University researchers investigated the role of metabolites in melanoma growth and spread. The team found significant differences in metabolite amounts between primary melanoma and surrounding tissues, suggesting that these substances may be responsible for tumor initiation and maintenance.
Increased diagnostic scrutiny is linked to rapid rise in melanoma diagnoses, according to a study published in The New England Journal of Medicine. Melanoma incidence has doubled among adults 65 and older over the past two decades, despite stable mortality rates.
A review of 13 studies found that individuals with skin of color are at increased risk of developing melanoma due to UV exposure. The study suggests that prolonged UV light exposure is a significant risk factor for melanoma in this population.
Researchers analyzed ten cancer patients with refractory melanoma and found that fecal microbiota transplant improved patient outcomes in three out of ten cases. The treatment was safe and feasible, suggesting a potential role in overcoming resistance to anti-PD-1 immunotherapy.
A new study published in the European Society of Human Reproduction and Embryology found that tanning bed use and sunburns may increase a woman's chances of developing endometriosis. The research analyzed data from over 116,000 women and found a higher risk among those who used tanning beds frequently or got sunburnt during teenage years.
A new study uses artificial intelligence to predict which patients with metastatic melanoma will respond well to immune checkpoint inhibitors. The algorithm achieves an accuracy rate of 80%, outperforming current predictive tools in a significant way.
A computational method combining clinicodemographic variables and deep learning of pre-treatment histology images accurately predicts response to immune checkpoint blockade. The model, validated in an independent cohort, achieves high accuracy and can stratify patients into high versus low risk for disease progression.
A new diagnostic system was developed by Lithuanian scientists, achieving over 90% accuracy in detecting melanoma from skin lesions. The non-invasive method combines data from optical spectrophotometry and ultrasound imaging technologies.
Younger patients with resected melanoma showed a benefit from adjuvant bevacizumab treatment, while older patients did not. The study suggests that sFRP2 may promote angiogenesis in older patients with melanoma, which is superseding the role of VEGF.
A key blood marker of cancer could be used to select the most effective treatment for melanoma, according to an Edith Cowan University study. The discovery has the potential to improve melanoma survival rates by identifying patients who may benefit from more aggressive treatments.
A new study has discovered that accumulated DNA damage in skin cells can be used to estimate the risk of deadly skin cancer. Researchers sequenced DNA from individual melanocytes and found a significant number of mutations associated with melanoma, even in people without visible moles.
Researchers found people with pale-colored melanomas are more likely to have an albinism gene mutation, which prevents brown pigment synthesis and increases skin cancer risk. This discovery could lead to personalized medicine and earlier treatment for patients with one mutated albinism gene.
People with pale-colored melanomas are more susceptible to developing rare genetic mutations associated with albinism. Researchers plan to collect samples to compare genotype and develop personalized monitoring for patients with one albinism gene mutation.
A collaborative study has uncovered new markers uniquely present on melanoma tumours that can be recognised by the immune system. These markers, known as spliced peptides, can be used to develop therapeutic vaccines to combat melanoma.
Scientists have discovered a rapid, inexpensive, and non-invasive method to track malignant melanoma using fluorescent molecules in urine samples. The technique allows doctors to diagnose and monitor the disease without requiring invasive biopsies.
A consensus statement evaluates the use of prognostic genetic expression profile testing in melanoma, cautioning against routine use due to limitations. The statement aims to assist clinicians in determining when and how gene expression profiling should be adopted in clinical practice.
Scientists at Sanford Burnham Prebys discovered that PRMT5 inhibitors can sensitize unresponsive melanoma to immune checkpoint therapy, enhancing antigen presentation and innate immunity. The study suggests that these inhibitors may also be effective in tumors of other types, providing a potential breakthrough for cancer treatment.
This study defines the mutation profile of SUM in Caucasians using next-generation sequencing-based genomic analysis, identifying frequently mutated genes. The most abundant mutations were found in KIT and NRAS, while BRAF was only present in 3% of cases, providing insights into the genetics of subungual melanoma.
A study of 34,000 biologic-treated patients found an increased melanoma risk compared to 135,000 conventional therapy patients. The results suggest a potential association between long-term use of biologics for inflammatory diseases and the development of melanoma.
Scientists have identified two genes responsible for a melanoma that develops near the tails of male highland-sheepshead hybrids. These findings provide insight into the genetic causes of hybrid dysfunction and its effects on disease, highlighting the importance of understanding gene interactions in different species.
Researchers found improved survival among patients with malignant melanoma who used desloratadine and loratadine, particularly in the age group 65 and older. The study suggests these antihistamines may also reduce the risk of new malignant melanoma cases.
Prolgolimab, a Russian original PD-1 inhibitor, has been approved for the treatment of advanced melanoma. The drug demonstrated significant antitumor activity and manageable safety in a phase II study, with 42 out of 126 patients experiencing an objective response.
Researchers identified 33 new regions and confirmed 21 previously reported regions linked to melanoma risk, shedding light on the immune system's role in the disease. The study also uncovered associations between melanoma and common genetic variants in the TP53 gene.
Researchers developed an AI algorithm that can classify cutaneous skin disorders, predict malignancy, and suggest primary treatment options. The algorithm improved the diagnostic accuracy of clinicians, including dermatologists and the general public, by up to 86.8%.
Death rates from metastatic melanoma dropped by nearly 18 percent between 2013 and 2016, thanks to new therapies that harness the immune system or target specific gene mutations. These advances in treatment have led to the largest yearly declines in deaths due to melanoma ever recorded.
A recent study funded by the European Academy of Dermatology and Venereology found a potential link between partner bereavement and skin cancer. Researchers discovered that individuals who experienced the loss of a partner had a decreased risk of being diagnosed with melanoma, but an increased risk of dying after diagnosis.